New Technology Shows Promise in Stopping Coronavirus from Replicating in Humans
What is GAFFL?

GAFFL connects travelers with similar itineraries to share costs and experiences around the world. Simply type the destination you are traveling to, connect with travelers and locals, chat, meet up and explore together!

8th Dec | 1 min read

Researchers from the University of Louisville say that they’ve developed a technology that shows promise in fighting COVID-19.

According to the news release from UofL the technology is based on a piece of synthetic DNA – an “aptamer” –  which targets and binds with a human protein called nucleolin. Early tests show that this aptamer can stop viruses, include COVID-19, from replicating in humans.  

Tired of traveling alone? Connect with users from over 190 countries to plan trips and travel together!

The University is now looking to fast-track the development of the technology and have applied to the FDA for the opportunity to treat patients who have serious cases of the coronavirus. 

The aptamer was originally applied in a variety of ways, including treating patients with multiple types of cancer. With the world suffering from the current global pandemic, one of the founders of the Synthetic DNA, Paula Bates, decided to partner with researcher Kenneth Palmer to help COVID-19 patients with their technology. 

"Like many scientists, as soon as I heard about the new coronavirus, I wanted to help and started to think about how my area of research might intersect with coronavirus research efforts," said Bates, a professor of medicine in a statement. 

Kenneth Palmer is the director of UofL’s Center for Predictive Medicine for Biodefense and Emerging Infectious Diseases (CPM), he was able to conduct experiments showing the effectiveness of the aptamer against the virus in doses that previous research has proven to be safe in patients.

These developments are certainly promising for the worlds fight against this virus. Currently, UofL is providing financial support for COVID-19 research, but additional funds are needed to continue the work over time. If you’d like to donate specifically to this research, you can do so here.

Tired of traveling alone? Connect with users from over 190 countries to plan trips and travel together!